UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

The Lancet (British edition), 2010-04, Vol.375 (9722), p.1278-1286

2010

Volltextzugriff (PDF)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV‐infected patients on antiretroviral therapy in sub‐Saharan Africa

Tropical medicine & international health, 2015-05, Vol.20 (5), p.569-580

2015

Volltextzugriff (PDF)

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda

HIV medicine, 2020-01, Vol.21 (1), p.21-29

2020

Volltextzugriff (PDF)

Assessment of arterial elasticity among HIV‐positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV medicine, 2015-04, Vol.16 (S1), p.109-118

2015

Volltextzugriff (PDF)

Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2965-2973

2010

Volltextzugriff (PDF)

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4575-4580

2011

Volltextzugriff (PDF)

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1938-1944

2014

Volltextzugriff (PDF)

Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/μl among HIV-1-infected Ugandan adults

Tropical medicine & international health, 2010-04, Vol.15 (4), p.396-404

2010

Volltextzugriff (PDF)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

The Lancet (British edition), 2010-01, Vol.375 (9709), p.123-131

2010

Volltextzugriff (PDF)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

HIV medicine, 2010-05, Vol.11 (5), p.334-344

2010

Volltextzugriff (PDF)

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

PLoS medicine, 2012-05, Vol.9 (5), p.e1001217

2012

Volltextzugriff (PDF)

DART and laboratory monitoring of HIV treatment – Authors' reply

The Lancet (British edition), 2010, Vol.375 (9719), p.979-980

2010

Volltextzugriff (PDF)

Expert consensus statement on the science of HIV in the context of criminal law

Journal of the International AIDS Society, 2018-07, Vol.21 (7), p.e25161-n/a

2018

Volltextzugriff (PDF)

Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV-Infected Adults in Africa Initiating Antiretroviral Therapy

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1271-1281

2008

Volltextzugriff (PDF)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1707-1718

2012

Volltextzugriff (PDF)

CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3329-3334

2014

Volltextzugriff (PDF)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy

BMC medicine, 2016-03, Vol.14 (1), p.50-50, Article 50

2016

Volltextzugriff (PDF)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study

PLoS medicine, 2013-10, Vol.10 (10), p.e1001542-e1001542

2013

Volltextzugriff (PDF)

Reduced Morbidity in the First Year After Initiating Highly Active Antiretroviral Therapy Among Ugandan Adults

International journal of infectious diseases, 2008, Vol.12, p.e203-e203

2008

Volltextzugriff (PDF)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy

AIDS (London), 2015-03, Vol.29 (5), p.609-618

2015

Volltextzugriff (PDF)

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions

Virus evolution, 2021, Vol.7 (2), p.veab055-veab055

2021

Volltextzugriff (PDF)

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

The Journal of infectious diseases, 2016-07, Vol.214 (2), p.226-236

2016

Volltextzugriff (PDF)

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Clinical infectious diseases, 2014-04, Vol.58 (7), p.1023-1026

2014

Volltextzugriff (PDF)

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants

Journal of acquired immune deficiency syndromes (1999), 2002-06, Vol.30 (2), p.200-215

2002

Volltextzugriff (PDF)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

PloS one, 2012-04, Vol.7 (4), p.e33672

2012

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(70)
Reviews
(1)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV‐infected patients on antiretroviral therapy in sub‐Saharan Africa

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda

Assessment of arterial elasticity among HIV‐positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/μl among HIV-1-infected Ugandan adults

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

DART and laboratory monitoring of HIV treatment – Authors' reply

Expert consensus statement on the science of HIV in the context of criminal law

Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV-Infected Adults in Africa Initiating Antiretroviral Therapy

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study

Reduced Morbidity in the First Year After Initiating Highly Active Antiretroviral Therapy Among Ugandan Adults

Pubertal development in HIV-infected African children on first-line antiretroviral therapy

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

Suchergebnisse filtern